Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyR Dienstmann, M J Mason, F A Sinicrope, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007E Van Cutsem, M Dicato, K Haustermans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2011
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010E Van Cutsem, M Dicato, R Geva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009E Van Cutsem, M Dicato, N Arber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2007
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006C Verslype, E Van Cutsem, M Dicato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2019
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trialS Stintzing, P Wirapati, H-J Lenz, et al.
Virchows Archiv : an International Journal of Pathology|December 18, 2012
KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assuranceJ R Dijkstra, D A M Heideman, G A Meijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSK Muro, F Lordick, T Tsushima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSK Muro, E Van Cutsem, Y Narita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trialsT Yoshino, J M Cleary, E Van Cutsem, et al.
Pageof 26